FDA Inspection
Reckitt Benckiser LLCReckitt Benckiser LLC – FDA Inspection, Oct 12, 2018
Record Details
This FDA Inspection record concerns Reckitt Benckiser LLC, with an inspection on October 12, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b3fb10bb-134f-46a9-9bf3-f15ea12b03f0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1068666
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Reckitt Benckiser LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 20, 2026 | Not classified | Atlanta District Office | |
| July 18, 2023 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Reckitt Benckiser LLC
- FDA Inspection 1299424 - 2026-01-20
- FDA Inspection 1211426 - 2023-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.